{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:56:14Z","timestamp":1792418174945,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Primary cutaneous neoplasms that lack definitive histologic and immunophenotypic evidence of differentiation are a heterogeneous group of tumors with diverse prognoses and management options. These include undifferentiated and dedifferentiated melanoma (UM\/DM), atypical fibroxanthoma (AFX), pleomorphic dermal sarcoma (PDS), and sarcomatoid squamous cell carcinoma. Diagnosis requires careful correlation between the clinicopathologic and molecular features, and the finding of a MAPK pathway variant commonly associated with melanoma may support the diagnosis of melanoma over other tumors in this group. To examine the frequency of typical melanoma-associated MAPK pathway-related variants (<jats:italic toggle=\"yes\">BRAF, NRAS, KIT, GNAQ, GNA11<\/jats:italic>) among a cohort of primary cutaneous sarcomatoid neoplasms, we conducted a retrospective analysis of 37 cases of immunohistologically unclassifiable primary cutaneous neoplasms, submitted for targeted NGS analysis. All cases lacked a history of a prior relevant tumor, were negative for melanocytic markers (S100, SOX10, HMB45, and Melan-A), or showed &lt;5% staining with 1 or 2 of these markers. Other lineage markers were negative. We identified typical melanoma driver variants in 7 cases (7\/37, 19%), including <jats:italic toggle=\"yes\">NRAS<\/jats:italic> (5\/37, 14%), <jats:italic toggle=\"yes\">KIT<\/jats:italic> (1\/37, 3%), and <jats:italic toggle=\"yes\">GNAQ<\/jats:italic> (1\/37, 3%). There were no significant differences in age, sex, tumor site, or mitotic rate between patients with and without a melanoma driver variant. Melanoma cases were thicker (16.3 vs. 9.25\u00a0mm, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.041) and more likely to show epithelioid cell phenotype (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.008). In our cohort, nearly 20% of patients with immunohistologically unclassifiable cutaneous tumors could be reclassified as having primary UM\/DM after molecular testing, thereby opening alternative management pathways.<\/jats:p>","DOI":"10.1097\/pas.0000000000002390","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:01:10Z","timestamp":1743760870000},"page":"650-657","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Molecular Analysis of Cutaneous Sarcomatoid Neoplasms Frequently Identifies Melanoma Driver Variants"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2792-6199","authenticated-orcid":false,"given":"Louise A.","family":"Jackett","sequence":"first","affiliation":[{"name":"Anatomical Pathology"},{"name":"Melanoma Research Victoria, Melbourne"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC"},{"name":"Melanoma Institute Australia"},{"name":"Faculty of Medicine and Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Anatomical Pathology"},{"name":"Molecular Pathology, Peter MacCallum Cancer Centre"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Snell","sequence":"additional","affiliation":[{"name":"Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsee","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Molecular Pathology, Peter MacCallum Cancer Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravan","family":"Yellenki","sequence":"additional","affiliation":[{"name":"Molecular Pathology, Peter MacCallum Cancer Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Snow","sequence":"additional","affiliation":[{"name":"Surgery"},{"name":"Melanoma Research Victoria, Melbourne"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Speakman","sequence":"additional","affiliation":[{"name":"Surgery"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Angel","sequence":"additional","affiliation":[{"name":"Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Khoo","sequence":"additional","affiliation":[{"name":"Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Min","family":"Pang","sequence":"additional","affiliation":[{"name":"Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serigne N.","family":"Lo","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia"},{"name":"Faculty of Medicine and Health"},{"name":"Charles Perkins Centre, The University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia"},{"name":"Faculty of Medicine and Health"},{"name":"Charles Perkins Centre, The University of Sydney"},{"name":"Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital & NSW Health Pathology, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Fox","sequence":"additional","affiliation":[{"name":"Anatomical Pathology"},{"name":"Surgery"},{"name":"Molecular Pathology, Peter MacCallum Cancer Centre"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gyorki","sequence":"additional","affiliation":[{"name":"Surgery"},{"name":"Melanoma Research Victoria, Melbourne"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"R1-20250618","first-page":"50682","article-title":"Dedifferentiated and undifferentiated neoplasms: a conceptual approach","volume":"5","author":"Baraban","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"R2-20250618","first-page":"235","article-title":"S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)","volume":"20","author":"Helbig","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/DAD.0000000000000237","article-title":"Metastatic atypical fibroxanthoma: a series of 11 cases with minimal or no subcutaneous involvement","volume":"37","author":"Wang","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1002\/cnr2.1583","article-title":"Pleomorphic dermal sarcoma: clinicopathological features and outcomes from a 5-year tertiary referral center experience","volume":"5","author":"Logan","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO Guideline Update","volume":"41","author":"Seth","year":"2023","journal-title":"J Clin Oncol"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/PAS.0000000000001645","article-title":"Dedifferentiated and undifferentiated melanomas: report of 35 new cases with literature review and proposal of diagnostic criteria","volume":"45","author":"Agaimy","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAS.0000000000000527","article-title":"Metastatic malignant melanoma with complete loss of differentiation markers (undifferentiated\/dedifferentiated melanoma): analysis of 14 patients emphasizing phenotypic plasticity and the value of molecular testing as surrogate diagnostic marker","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"100165","DOI":"10.1016\/j.modpat.2023.100165","article-title":"Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: mutational signature analysis and immunotherapy response","volume":"36","author":"Kasago","year":"2023","journal-title":"Mod Pathol"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/10668969211052238","article-title":"Undifferentiated melanoma resembling undifferentiated round cell sarcoma: the diagnostic power of molecular melanoma signature","volume":"30","author":"Kavuncuoglu","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/his.12305","article-title":"BRAF mutation in \u2018sarcomas\u2019: a possible method to detect de-differentiated melanomas","volume":"64","author":"Cipriani","year":"2014","journal-title":"Histopathology"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41379-021-00857-z","article-title":"Clinicopathological spectrum and genomic landscape of de-\/trans-differentiated melanomas","volume":"34","author":"Ferreira","year":"2021","journal-title":"Mod Pathol"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cup.13646","article-title":"CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: a cautionary (and molecularly annotated) tale","volume":"47","author":"Lefferts","year":"2020","journal-title":"J Cutan Pathol"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/dermatopathology8040051","article-title":"Dedifferentiated melanoma: a diagnostic histological pitfall-review of the literature with case presentation","volume":"8","author":"Cazzato","year":"2021","journal-title":"Dermatopathology (Basel)"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/DAD.0000000000002092","article-title":"Sarcomatoid dedifferentiated melanoma: the diagnostic role of next-generation sequencing","volume":"44","author":"Valiga","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2559.2007.02823.x","article-title":"Divergent differentiation in malignant melanomas: a review","volume":"52","author":"Banerjee","year":"2008","journal-title":"Histopathology"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"102060","DOI":"10.1016\/j.ctrv.2020.102060","article-title":"Dedifferentiated melanomas: morpho-phenotypic profile, genetic reprogramming, and clinical implications","volume":"88","author":"Massi","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determination of BRAF mutations in primary melanoma","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41467-020-16276-8","article-title":"Whole-genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumors","volume":"11","author":"Johansson","year":"2020","journal-title":"Nat Commun"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"28086","DOI":"10.18632\/oncotarget.8578","article-title":"The genetic profile of GNAQ-mutated blue melanocytic neoplasms revealed mutations in genes associated with genomic instability and the PI3K pathway","volume":"7","author":"P\u00e9rez-Alea","year":"2016","journal-title":"Oncotarget"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/genes12070974","article-title":"Clinicopathological and genomic profiles of atypical fibroxanthoma and pleomorphic dermal sarcoma identify overlapping signatures with a high mutational burden","volume":"12","author":"Ak","year":"2021","journal-title":"Gene (Basel)"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/modpathol.2017.146","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1\/2 and FAT1 mutations and similar DNA copy number alteration profiles","volume":"31","author":"Griewank","year":"2018","journal-title":"Mod Pathol"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/hupa.2001.28953","article-title":"H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma","volume":"32","author":"Sakamoto","year":"2001","journal-title":"Hum Pathol"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.2013.168","article-title":"TERT promoter mutations are common in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"27","author":"Griewank","year":"2013","journal-title":"Mod Pathol"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat Genet"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0000000000000451","article-title":"NF1 mutations are common in desmoplastic melanoma","volume":"39","author":"Wiesner","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:00:12Z","timestamp":1750280412000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002390","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}